“Life-changing” diabetes monitors roll-out ahead of schedule
The roll out of the monitors has helped 30,000 people across the country with their type I diabetes
Read More
Tag: type I
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
